BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 32591182)

  • 1. Therapeutic conflict in patients with COVID-19 and glaucoma.
    Millá Griñó E; Muniesa Royo MJ; Pazos López M
    Med Clin (Barc); 2020 Aug; 155(4):182. PubMed ID: 32591182
    [No Abstract]   [Full Text] [Related]  

  • 2. [Is there a need for ophthalmological surveillance in the case of short-term hydroxychloroquine treatment during this COVID-19 pandemic?].
    Defoort-Dhellemmes S
    J Fr Ophtalmol; 2020 Jun; 43(6):548-549. PubMed ID: 32451138
    [No Abstract]   [Full Text] [Related]  

  • 3. Regulators split on antimalarials for COVID-19.
    Jaffe S
    Lancet; 2020 Apr; 395(10231):1179. PubMed ID: 32278373
    [No Abstract]   [Full Text] [Related]  

  • 4. Ventricular arrhythmia risk due to chloroquine / hydroxychloroquine treatment for COVID-19: Should it be given.
    Malviya A
    Indian Heart J; 2020; 72(2):131-132. PubMed ID: 32534688
    [No Abstract]   [Full Text] [Related]  

  • 5. COVID-19 and Antimalarial Drugs: Harms Outweigh Benefits.
    Halm MA
    Am J Crit Care; 2020 Nov; 29(6):489-492. PubMed ID: 32839815
    [No Abstract]   [Full Text] [Related]  

  • 6. Drug reaction with eosinophilia and systemic symptoms syndrome to hydroxychloroquine, an old drug in the spotlight in the COVID-19 era.
    Grandolfo M; Romita P; Bonamonte D; Cazzato G; Hansel K; Stingeni L; Conforti C; Giuffrida R; Foti C
    Dermatol Ther; 2020 Jul; 33(4):e13499. PubMed ID: 32362051
    [No Abstract]   [Full Text] [Related]  

  • 7. Use of Chloroquine and Hydroxychloroquine in COVID-19 and Cardiovascular Implications: Understanding Safety Discrepancies to Improve Interpretation and Design of Clinical Trials.
    Oren O; Yang EH; Gluckman TJ; Michos ED; Blumenthal RS; Gersh BJ
    Circ Arrhythm Electrophysiol; 2020 Jun; 13(6):e008688. PubMed ID: 32436730
    [No Abstract]   [Full Text] [Related]  

  • 8. [Potential harms associated with 4-aminoquinoline treatment].
    Svensson M
    Lakartidningen; 2020 Apr; 117():. PubMed ID: 32365215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydroxychloroquine as prophylaxis or treatment for COVID-19: What does the evidence say?
    Nina PB; Dash AP
    Indian J Public Health; 2020 Jun; 64(Supplement):S125-S127. PubMed ID: 32496241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Risks of Prescribing Hydroxychloroquine in COVID-19-Infected Patients With Schizophrenia.
    Uvais NA
    Prim Care Companion CNS Disord; 2020 Apr; 22(3):. PubMed ID: 32369686
    [No Abstract]   [Full Text] [Related]  

  • 11. COVID-19 and hydroxychloroquine: Is the wonder drug failing?
    Paliani U; Cardona A
    Eur J Intern Med; 2020 Aug; 78():1-3. PubMed ID: 32553587
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hazard of acquired long QT syndrome during coronavirus pandemic. Focus on hydroxychloroquine].
    Tomcsányi J; Tomcsányi K
    Orv Hetil; 2020 Apr; 161(17):689-691. PubMed ID: 32324363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Saga of Hydroxychloroquine and COVID-19: A Cautionary Tale.
    Schluger NW
    Ann Intern Med; 2020 Oct; 173(8):662-663. PubMed ID: 32673059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does hydroxychloroquine combat COVID-19? A timeline of evidence.
    Alia E; Grant-Kels JM
    J Am Acad Dermatol; 2020 Jul; 83(1):e33-e34. PubMed ID: 32283236
    [No Abstract]   [Full Text] [Related]  

  • 15. The impact of hydroxychloroquine shortages on patients with dermatological conditions during COVID-19 pandemic.
    Shah M; Sachdeva M; Dodiuk-Gad RP
    Dermatol Ther; 2020 Jul; 33(4):e13524. PubMed ID: 32383251
    [No Abstract]   [Full Text] [Related]  

  • 16. Possible Consequences of a Shortage of Hydroxychloroquine for Patients with Systemic Lupus Erythematosus amid the COVID-19 Pandemic.
    Peschken CA
    J Rheumatol; 2020 Jun; 47(6):787-790. PubMed ID: 32269064
    [No Abstract]   [Full Text] [Related]  

  • 17. COVID-19 and Chloroquine/Hydroxychloroquine: Is There Ophthalmological Concern?
    Marmor MF
    Am J Ophthalmol; 2020 Aug; 216():A1-A2. PubMed ID: 32439074
    [No Abstract]   [Full Text] [Related]  

  • 18. COVID-19 and Depression.
    Shader RI
    Clin Ther; 2020 Jun; 42(6):962-963. PubMed ID: 32362345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suspected Hydroxychloroquine-Induced Sinus Bradycardia and QTc Prolongation in a Patient with COVID-19.
    Kang Y; Wang H; Chen H; Wang B; Yang Y; Zhao X; Ran Q; Wei J
    Int Heart J; 2020 Sep; 61(5):1056-1058. PubMed ID: 32921678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meta-analysis of Effect of Statins in Patients with COVID-19.
    Kow CS; Hasan SS
    Am J Cardiol; 2020 Nov; 134():153-155. PubMed ID: 32891399
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.